About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Nashville | 367 Studies

Clinical Trials LymphomaNashville

Lymphoma Clinical Trials in Nashville

Find 367 clinical trials for lymphoma near Nashville, Tennessee. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Nashville

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 367 trials

CompletedDonor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersRATIONALE: Umbilical cord blood transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy that was used to kill cancer cells.NCT00055653·Duarte, California and 24 others CompletedTrial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade LymphomaThe goal of this multi-center Phase II study is to add bortezomib to the highly active regimen of bendamustine and rituximab.NCT01029730·Jonesboro, Arkansas and 19 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantRATIONALE: Reducing the amount of drugs used to prevent transplant rejection may help a person's body kill tumor cells.NCT00002657·Mobile, Alabama and 85 others

RecruitingA Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )The purpose of this study is to find the best dose of the drug and measure the safety and efficacy of LY4152199 in participants with previously treated B-cell malignancies.NCT07101328·Duarte, California and 50 others

Active not recruitingA Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer.NCT04224493·Mobile, Alabama and 203 others

CompletedStudy of Ibrutinib in Combination With Rituximab in Previously Untreated Subjects With Follicular LymphomaThis is an open-label, Phase 2 study designed to assess the efficacy and safety of ibrutinib combined with rituximab in previously untreated subjects with Follicular Lymphoma (FL).NCT01980654·Burbank, California and 11 others

CompletedIfosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell LymphomaIn this Multicenter trial, we will evaluate the feasibility, toxicity, and efficacy of treatment with 90Y Zevalin following a short course of salvage chemotherapy in patients with…NCT00193505·Nashville, Tennessee

CompletedALRN-6924 in Patients With Advanced Solid Tumors or LymphomasThis study evaluates the anti-tumor effects of ALRN-6924 in patients with advanced solid tumors or lymphomas with WT TP53.NCT02264613·Birmingham, Alabama and 12 others

TerminatedEfficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin LymphomasThe primary objective of this study is to evaluate the effect of the addition of idelalisib to rituximab on progression-free survival (PFS) in adults with previously treated…NCT01732913·Huntsville, Alabama and 102 others

TerminatedMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)RATIONALE: Mycophenolate mofetil added to immunosuppressive treatment regimens may be effective in treating newly diagnosed chronic graft-versus-host disease caused by stem cell…NCT00089141·Duarte, California and 15 others

CompletedTofacitinib Ointment For Chronic Plaque PsoriasisThe study is beng done to test if tofacitinib ointment is safe and effective for people with plaque psoriasis.NCT01831466·Hot Springs, Arkansas and 53 others

CompletedA Study in Participants With Moderate to Severe PsoriasisThe primary purpose for this study is to help answer the following research questions * The safety of ixekizumab (LY2439821) and any side effects that might be associated with it.NCT01107457·Bakersfield, California and 33 others

CompletedACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic MalignanciesThis study is evaluating the safety, pharmacodynamics (PD), and efficacy of acalabrutinib and pembrolizumab in hematologic malignancies.NCT02362035·Tucson, Arizona and 18 others

RecruitingDALY II USA/ MB-CART2019.1 for DLBCLDALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with…NCT04792489·Birmingham, Alabama and 31 others

Active not recruitingEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH treatment trial studies how well ensartinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with ALK or…NCT03213652·Birmingham, Alabama and 125 others

CompletedVemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well vemurafenib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with BRAF V600…NCT03220035·Birmingham, Alabama and 115 others

CompletedDonor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseRATIONALE: A bone marrow transplant from a brother or sister may be able to replace blood-forming cells that were destroyed by chemotherapy or radiation therapy.NCT00118326·Nashville, Tennessee and 1 other

TerminatedIdelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic LymphomaThe primary objective of this study is to evaluate the overall response rate (ORR) and complete response (CR) rate to treatment with idelalisib in combination with rituximab in…NCT02258529·Long Beach, California and 5 others

RecruitingIDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic CancersThis is an open label, Phase 1/2, first-in-human, multiple ascending dose, and dose-expansion study of IDP-023 administered as a single agent and in combination with or without…NCT06119685·Los Angeles, California and 11 others

CompletedAMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin LymphomaRATIONALE: Monoclonal antibodies, such as AMG-479, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00562380·Nashville, Tennessee

PreviousPage 2 of 19Next

Other Conditions in Nashville

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia